Development of infections among patients with myasthenia gravis undergoing immunotherapy

ConclusionAge at onset of MG was a significant contributor to the development of infection. Generalized late-onset MG is the most susceptible to infection and should be carefully monitored during immunotherapy.

Source: Clinical and Experimental Neuroimmunology - August 4, 2022 Category: Neurology Authors: Shingo Konno, Takafumi Uchi, Jun Isonishi, Mari Matsushima, Hideo Kihara, Hideki Sugimoto, Toshiki Fujioka Tags: ORIGINAL ARTICLE Source Type: research